Brian J. Granger

Family Medicine

10240 San Jose Blvd
Jacksonville, FL 32257

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice.

Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice.

Journal: Nature communications

Published: September 18, 2024

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations.

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations.

Journal: Frontiers in microbiology

Published: May 04, 2022

Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus.

Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 06, 2021

Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics.

Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics.

Journal: Nature biomedical engineering

Published: March 09, 2020

Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection.

Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection.

Journal: Molecular therapy. Methods & clinical development

Published: January 09, 2020

Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family.

Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 12, 2018

Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment.

Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment.

Journal: Vaccines

Published: April 30, 2018

A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika.

A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 11, 2018

A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen.

A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen.

Journal: NPJ vaccines

Published: December 01, 2017

Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.

Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.

Journal: Frontiers in immunology

Published: September 12, 2017

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.

Journal: Scientific reports

Published: December 05, 2016

The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivative.

The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivative.

Journal: Clinical and vaccine immunology : CVI

Published: July 18, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026